Supporting Evidence

95% efficacy claim does not stand up

Andrew Bridgen is absolutely right to ask difficult questions

The MHRA have just authorised Pfizer Cominarty for infants and toddlers. Will the JCVI just fall in line or will they finally show some ethical resolve?

'Myocarditis is more common after covid than after the vaccine' is a statement often made in response to safety concerns raised but what is the evidence for these assertions?

Governments need a way out of the mess they have created and an overhaul of drug regulation would achieve this. The UK drug regulator, the MHRA, did not carry out the toxicity, biodistribution and pharmacokinetics studies that are required of new drugs because of the political pressure to approve.

Although there have been several epidemiological analyses of myocarditis, that simple comparison is never made. Where uninjected people are looked at specifically, there is no evidence of an increase in incidence. HART has previously summarised the data after infection in the injected compared to the uninjected. An alternative approach is to look at how common myocarditis is over time. Did the incidence increase with the arrival of covid in 2020 or the arrival of injections in 2021?

Latest ONS deaths by vaccination status

Pharma funding inevitably means lack of neutrality

Letter delivered to MHRA outlines concerns.

The statistical jiggery-pokery employed since 2020 is so outrageous it is perhaps best viewed through the lens of (dark) comedy, so we forewarn you in advance that — in a change from our usual (possibly over-sober) tone — the following article has been written in a somewhat jocular manner, despite covering a topic that is very much not a laughing matter.

Andrew Bridgen MP finally secures an adjournment debate

We must not repeat mistakes from history.

Other countries more efficient at noticing issues.

Despite emerging short-term and unknown longer-term side effects.

My health is not your business

The US White House has appointed a coronavirus “Vaccine Czar” from Big Pharma to oversee something dubbed Operation Warp Speed.

This article by F. William Engdahl first published on April 29, 2020 focusses on the dubious Covid models used to justify the lockdowns and closure of economic activity Worldwide. The architects of these models were generously funded by the Gates Foundation. In early 2021, we are now in a position to assess the devastating social and […]

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). Visit and follow us on Instagram at @crg_globalresearch. *** The US Government regulator for drugs, the Food and Drug Administration, has just announced that it has voted full approval […]

The most influential organization in the world with nominal responsibility for global health and epidemic issues is the United Nations’ World Health Organization, WHO, based in Geneva.

Arguably, no one has been more active in promoting and funding research on vaccines aimed at dealing with coronavirus than Bill Gates and the Bill and Melinda Gates Foundation.

Not only are the coronavirus models being used by WHO and the most national health agencies based on highly dubious methodologies, and not only are the tests being used of wildly different quality, that only indirectly confirm antibodies of a possible COVID-19 illness. Now the actual designations of deaths related to coronavirus are being revealed […]

The major funder of health research stands to gain financially from the pandemic, raising questions about transparency and accountability An increasingly clear feature of the covid-19 pandemic is that the public health response is being driven not only by governments and multilateral institutions, such as the World Health Organisation, but also by a welter of public-private partnerships involving drug companies and private foundations. One leading voice to emerge is the Wellcome Trust, one of the world’s top funders of health research, whose sprawling charitable activities in the pandemic include co-leading a WHO programme to support new covid-19 therapeutics. The Access to Covid-19 Tools (ACT) Accelerator project hopes to raise billions of dollars and deliver hundreds of millions of treatment courses in the year ahead, including dexamethasone and a number of monoclonal antibodies.1 At the same time, The BMJ finds, Wellcome itself holds investments in companies producing these same treatments. Financial disclosures from late 2020 show that Wellcome has a £275m (€318m; $389m) stake in Novartis, which manufactures dexamethasone and is investigating additional therapeutics. And Roche, in which Wellcome holds a £252m stake,2 is helping to manufacture monoclonal antibodies with Regeneron. Both Roche and Novartis report having had conversations with WHO’s ACT Accelerator about their therapeutic drugs.3 Wellcome’s financial interests have been published on the trust’s website and through financial regulatory filings but do not seem to have been disclosed as financial conflicts of interest in the context of Wellcome’s work on covid-19, even as they show that the trust is positioned to potentially gain from the pandemic financially. Revelations of the Wellcome Trust’s financial conflicts of interest follow news reports that another charity, the Gates Foundation, is also positioned to potentially benefit financially from its leading role in the pandemic response. An investigation by the Nation revealed …

Unheroic NHS Doc - twitter.com/tcp_dr - https://tcp.art.blog/

Dr. Peter McCullough is under fire from the American Board of Internal Medicine (A.B.I.M.), who is threatening his medical license for “providing false and inaccurate information to patients”. Senator Ron Johnson has responded with a call for A.B.I.M. and Dr. McCullough to participate in an open hearing on Capitol Hill, and put it all on […]

The Covid testimony of Dr Peter McCullough – Part 2: The vaccines are killing people

The Covid testimony of Dr Peter McCullough – Part 2: The vaccines are killing people

The Covid testimony of Dr Peter McCullough – Part 1: Cancelled for telling the truth

The Covid testimony of Dr Peter McCullough – Part 1: Cancelled for telling the truth

NEW BOOK by Author John Leake and Dr. Peter McCullough to be published on April 15, 2022. THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex. https://rb.gy/d6edbk Dr. Peter McCullough has been the world's most prominent and vocal advocate for early outpatient treatment of SARS-CoV-2 (COVID-19) Infection in order to prevent hospitalization and death. On May 19, 2021, I interviewed him about his efforts as a treating physician and researcher. From his unique vantage point, he has observed and documented a PROFOUNDLY DISTURBING POLICY RESPONSE to the pandemic -- a policy response that may prove to be the greatest malpractice and malfeasance in the history of medicine and public health. Dr. McCullough is an internist, cardiologist, epidemiologist, and Professor of Medicine at Texas A & M College of Medicine, Dallas, TX USA. Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 40 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill and on FOX NEWS Channel. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, and New Hampshire Senate concerning many aspects of the pandemic response. Peter A. McCullough, MD, MPH, FACP, FACC, FAHA, FCRSA, FCCP, FNKF, FNLA Professor of Medicine, Texas A & M College of Medicine Board Certified Internist and Cardiologist President Cardiorenal Society of America Editor-in-Chief, Reviews in Cardiovascular Medicine Editor-in-Chief, Cardiorenal Medicine Senior Associate Editor, American Journal of Cardiology For more information about Dr. McCullough, please visit: https://www.heartplace.com/dr-peter-a-mccullough